stockrowEnvista Holdings Corporation
NVST Healthcare Medical Instruments & Supplies
Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024.
- Revenue
- +3.22%
- EPS
- +1,855.6%
- Free cash flow
- −6.48%
- Total debt
- −1.13%
Quarter to September 2026, against a year earlier
Follow NVST
Alert me
Envista Holdings Corporation (NVST) Return on assets
Envista Holdings Corporation's return on assets over the twelve months to 30 September 2026 was 11.3%, up 10.4 percentage points from fiscal 2025 (0.85%). Over the past ten years it has ranged from −18.7% (fiscal 2024) to 7.90% (fiscal 2018); the current reading is higher than 50% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 0.85% | 19.56 |
| FY2024 | −18.7% | (17.19) |
| FY2023 | −1.52% | (5.21) |
| FY2022 | 3.69% | (1.37) |
| FY2021 | 5.06% | 4.55 |
| FY2020 | 0.51% | (3.12) |
| FY2019 | 3.63% | (4.27) |
| FY2018 | 7.90% | 2.81 |
| FY2017 | 5.09% | 5.09 |
| FY2016 | 0.00% | — |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| NVST Envista Holdings Corporation | 11.3% |
| MMSI Merit Medical Systems, Inc. compare | 5.76% |
| STVN Stevanato Group S.p.A. compare | 5.50% |
| ATRC AtriCure, Inc. compare | 2.20% |
| ICUI ICU Medical, Inc. compare | 1.50% |
| WRBY Warby Parker Inc. compare | 1.00% |
| MMED MiniMed Group, Inc. compare | −6.27% |
| TFX Teleflex Incorporated compare | −14.6% |
| PLSE Pulse Biosciences, Inc compare | −54.0% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on NVST
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement